Page last updated: 2024-11-04

succinylacetone and Autoimmune Diseases

succinylacetone has been researched along with Autoimmune Diseases in 1 studies

succinylacetone: inhibitor of heme biosynthesis
4,6-dioxoheptanoic acid : A dioxo monocarboxylic acid that is heptanoic acid in which oxo groups replace the hydrogens at positions 4 and 6. It is an abnormal metabolite of the tyrosine metabolic pathway and a marker for type 1 tyrosinaemia.

Autoimmune Diseases: Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.

Research Excerpts

ExcerptRelevanceReference
"The effects of succinylacetone (SA) on the development of S-antigen-induced experimental autoimmune uveitis (EAU) in the rat were studied."7.67Treatment of experimental autoimmune uveitis in the rat with systemic succinylacetone. ( Blaese, RM; Hess, RA; Nussenblatt, RB; Palestine, AG; Skolik, SA, 1988)
"The effects of succinylacetone (SA) on the development of S-antigen-induced experimental autoimmune uveitis (EAU) in the rat were studied."3.67Treatment of experimental autoimmune uveitis in the rat with systemic succinylacetone. ( Blaese, RM; Hess, RA; Nussenblatt, RB; Palestine, AG; Skolik, SA, 1988)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Skolik, SA1
Palestine, AG1
Blaese, RM1
Nussenblatt, RB1
Hess, RA1

Other Studies

1 other study available for succinylacetone and Autoimmune Diseases

ArticleYear
Treatment of experimental autoimmune uveitis in the rat with systemic succinylacetone.
    Clinical immunology and immunopathology, 1988, Volume: 49, Issue:1

    Topics: Animals; Autoimmune Diseases; Dose-Response Relationship, Drug; Female; Heptanoates; Heptanoic Acids

1988